RT Journal Article
SR Electronic
T1 Adjusting for reporting lags in remote regions to improve malaria surveillance: Guyana as a case study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.08.20178756
DO 10.1101/2020.09.08.20178756
A1 Menkir, Tigist F.
A1 Cox, Horace
A1 Poirier, Canelle
A1 Saul, Melanie
A1 Jones-Weekes, Sharon
A1 Clementson, Collette
A1 de Salazar, Pablo M.
A1 Santillana, Mauricio
A1 Buckee, Caroline O.
YR 2020
UL http://medrxiv.org/content/early/2020/09/09/2020.09.08.20178756.abstract
AB Time lags in reporting to national surveillance systems represent a major barrier for the control of infectious diseases, preventing timely decision making and resource allocation. This issue is particularly acute for infectious diseases like malaria, which often impact rural and remote communities the hardest. In Guyana, a country located in South America, poor connectivity among remote malaria-endemic regions hampers surveillance efforts, making reporting delays a key challenge for elimination. Here, we analyze 13 years of malaria surveillance data, identifying key correlates of time lags between clinical cases occurring and being added to the central data system. We develop nowcasting methods that use historical patterns of reporting delays to estimate occurred-but-not-reported monthly malaria cases. To assess their performance, we implemented them retrospectively, using only information that would have been available at the time of estimation, and found that they substantially enhanced the estimates of malaria cases. Specifically, we found that the best performing models achieved up to two- to four-fold improvements in accuracy (or error reduction) over known cases in selected regions. Our approach provides a simple, generalizable tool to improve malaria surveillance in endemic countries.Competing Interest StatementThe authors have declared no competing interest.Funding StatementTFM was supported by the National Institute of General Medical Sciences of the National Institutes of Health U54GM088558. PMD was supported by the Fellowship Foundation Ramon Areces. COB was supported by a NIGMS Maximizing Investigators Research Award MIRA R35GM124715-02. MS was supported by the National Institute of General Medical Sciences of the National Institutes of Health R01 GM130668. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ministry of Public Health, Guyana granted access to non-identifiable surveillance data obtained from the Malaria Program /Vector Control Services under IRB exemption. Further, IRB exemption was obtained from Harvard School of Public Health (US), Human Research Protection Program, Protocol number IRB18-1638.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw data and code will be made available upon publication